Peter Shapland

Peter Shapland began their work experience in 1999 as a Postdoc at Roche Pharmaceuticals. Peter then joined GlaxoSmithKline in 2001, where they held various roles including Principal Scientist and Investigator. Peter'sresponsibilities at GlaxoSmithKline included chemical and engineering development, technical transfer, and regulatory documentation. Currently, Peter is working as a Senior Principal Scientist at Pharmaron. The details of their role at Pharmaron are not provided.

Peter Shapland pursued their education in the field of Chemistry. Peter completed their BSc degree at The University of Manchester from 1992 to 1996. Peter then went on to obtain a PhD in Total synthesis from the same university, which they completed from 1997 to 2000. Following their PhD, they pursued a Postdoc degree in Synthetic Chemistry at the University of Michigan from 2000 to 2001.